These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17195533)

  • 1. [Combined antiviral treatment of a patient with chronic mixed hepatitis (HBV + HCV)].
    Fedorchenko SV; Martynovich TL
    Ter Arkh; 2006; 78(11):76-7. PubMed ID: 17195533
    [No Abstract]   [Full Text] [Related]  

  • 2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of BHIVA guidelines for HIV and hepatitis B or C co-infection.
    Brook MG
    J HIV Ther; 2003 Nov; 8(4):85-8. PubMed ID: 14671505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C and B (HCV, HBV)].
    Violante MD
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():101-3. PubMed ID: 17037789
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of patients co-infected with HBV and HCV.
    Coffin CS; Terrault NA
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
    Alberti A; Clumeck N; Collins S; Gerlich W; Lundgren J; Palù G; Reiss P; Thiebaut R; Weiland O; Yazdanpanah Y; Zeuzem S;
    J Hepatol; 2005 May; 42(5):615-24. PubMed ID: 15916745
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic viral hepatitis and chronic kidney disease.
    Chacko EC; Surrun SK; Mubarack Sani TP; Pappachan JM
    Postgrad Med J; 2010 Aug; 86(1018):486-92. PubMed ID: 20709771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.
    Vallet-Pichard A; Pol S
    J Hepatol; 2004 Jul; 41(1):156-66. PubMed ID: 15246224
    [No Abstract]   [Full Text] [Related]  

  • 11. Guideline watch. New guidelines on treating chronic hepatitis B and C in HIV-coinfected patients.
    Gandhi RT
    AIDS Clin Care; 2005 Jul; 17(7):65. PubMed ID: 16110574
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of HBV- and HCV-induced end stage liver disease.
    Mutimer DJ; Lok A
    Gut; 2012 May; 61 Suppl 1():i59-67. PubMed ID: 22504920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of viral hepatitis in hematologic malignancies.
    Firpi RJ; Nelson DR
    Blood Rev; 2008 May; 22(3):117-26. PubMed ID: 18343002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of cytokine level and T-cell lymphocyte response to B and C hepatic viral antigens in patients with type C and B+C hepatitis receiving antiviral therapy].
    Sobolevskaia OL; Korochkina OV
    Klin Med (Mosk); 2007; 85(7):63-6. PubMed ID: 17882815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D; Halota W
    Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic viral hepatitis in patients with renal disease.
    Fabrizi F; Martin P; Bunnapradist S
    Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.